Stay updated on Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange Detected- Added a government funding lapse notice with operating status guidance for NIH Clinical Center and links to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed the previous v3.1.0 version tag.SummaryDifference5%
- Check18 days agoChange DetectedUpdated Melanoma topic tagging to a broader entry and refreshed contact and revision details (added new phone numbers, email, and Revision v3.1.0; removed older Melanoma label and Revision v3.0.2).SummaryDifference0.7%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link/button has been removed.SummaryDifference0.3%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%
- Check47 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new medical terms related to skin and connective tissue diseases, specifically melanoma and treatments like pembrolizumab and talimogene laherparepvec.SummaryDifference4%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.